Biggest News Aggregation in the World
📰 Nasdaq Coll News

Page 6 - Nasdaq Coll News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Coll. Real-time updates on events, politics, business and more.

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Quarterly Sales of $78.95 Million

Equities research analysts forecast that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will post sales of $78.95 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings. The lowest sales estimate is $75.10 million and the highest is $83.27 million. Collegium Pharmaceutical posted sales of $87.72 […]
Thomson Reuter Scott Dreyer Principal Financial Group Inc Zacks Investment Research Emerald Advisers Needham Company

$0.97 Earnings Per Share Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter

Brokerages expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to announce $0.97 earnings per share for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $0.82 to $1.03. Collegium Pharmaceutical posted earnings of $0.41 per share in the same quarter last year, which would suggest […]
Hong Kong Piper Sandler Scott Dreyer Harel Insurance Investments Financial Services Ltd Zacks Investment Research Geneos Wealth Management Inc

$78.95 Million in Sales Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter

Wall Street brokerages expect that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will report $78.95 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $75.10 million to $83.27 million. Collegium Pharmaceutical reported sales of $87.72 million during the same quarter […]
New York United States Piper Sandler Scott Dreyer Collegium Pharmaceutical Inc Harel Insurance Investments Financial Services Ltd

Zacks: Brokerages Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) to Post $0.99 EPS

Wall Street brokerages expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to post earnings of $0.99 per share for the current quarter, according to Zacks. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings, with the lowest EPS estimate coming in at $0.87 and the highest estimate coming in at $1.03. Collegium Pharmaceutical reported earnings […]
Hong Kong Piper Sandler Scott Dreyer Harel Insurance Investments Financial Services Ltd Zacks Investment Research Geneos Wealth Management Inc

Collegium Pharmaceutical (NASDAQ:COLL) Cut to C+ at TheStreet

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) was downgraded by stock analysts at TheStreet from a “b-” rating to a “c+” rating in a research note issued on Monday, TheStreetRatingsTable reports. Several other research firms have also recently commented on COLL. HC Wainwright boosted their target price on Collegium Pharmaceutical from $26.00 to $29.00 and gave […]
New York United States Piper Sandler Scott Dreyer Zacks Investment Research Needham Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Research Analysts' Weekly Ratings Updates for Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical (NASDAQ: COLL) recently received a number of ratings updates from brokerages and research firms: 4/11/2022 – Collegium Pharmaceutical was downgraded by analysts at TheStreet from a “b-” rating to a “c+” rating. 4/6/2022 – Collegium Pharmaceutical had its price target raised by analysts at Needham & Company LLC from $34.00 to $36.00. They […]
United States Piper Sandler Scott Dreyer Principal Financial Group Inc Zacks Investment Research Needham Company

$79.05 Million in Sales Expected for Collegium Pharmaceutical, Inc. (NASDAQ:COLL) This Quarter

Brokerages predict that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will report sales of $79.05 million for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Collegium Pharmaceutical’s earnings. The highest sales estimate is $83.33 million and the lowest is $75.10 million. Collegium Pharmaceutical posted sales of $87.72 million in the […]
Scott Dreyer Securities Exchange Commission Principal Financial Group Inc Zacks Investment Research Needham Company Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Earnings of $1.10 Per Share

Wall Street analysts expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) to announce earnings of $1.10 per share for the current quarter, according to Zacks. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings. The lowest EPS estimate is $0.92 and the highest is $1.21. Collegium Pharmaceutical posted earnings per share of $0.41 during the […]
Hong Kong Piper Sandler Scott Dreyer Harel Insurance Investments Financial Services Ltd Securities Exchange Commission Zacks Investment Research

Zacks: Analysts Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Will Post Quarterly Sales of $83.53 Million

Wall Street analysts predict that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will post $83.53 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Collegium Pharmaceutical’s earnings, with estimates ranging from $80.58 million to $86.48 million. Collegium Pharmaceutical posted sales of $87.72 million during the same […]
Piper Sandler Scott Dreyer Geode Capital Management Securities Exchange Commission Zacks Investment Research Nuveen Asset Management

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science